Study S000263

Effect Of Semaglutide In Coronary Atherosclerotic Plaqus Assessed by Coronay CT

ClinicalTrials.gov record

Registration

Registration: NCT05071417
Acronym: SEPLA
Study type: INTERVENTIONAL
Phase: PHASE3
Masking: NONE
Status: UNKNOWN
Enrollment: 120
Start: 2021-11
Primary completion: 2024-12
Lead sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Conditions: Atheroscleroses, Coronary
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Plaque burden modification assessed by coronary CT and plaque quantification [18 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.